[go: up one dir, main page]

SK163095A3 - Bis-imides and pharmaceutical compositions on their base - Google Patents

Bis-imides and pharmaceutical compositions on their base Download PDF

Info

Publication number
SK163095A3
SK163095A3 SK1630-95A SK163095A SK163095A3 SK 163095 A3 SK163095 A3 SK 163095A3 SK 163095 A SK163095 A SK 163095A SK 163095 A3 SK163095 A3 SK 163095A3
Authority
SK
Slovakia
Prior art keywords
dicarboximido
propylamino
nitro
mhz
nmr
Prior art date
Application number
SK1630-95A
Other languages
English (en)
Slovak (sk)
Inventor
Arthur D Patten
Gregory J Pacofsky
Steven P Seitz
Emeka A Akamike
Robert J Cherney
Robert F Kaltenbach
Michael J Orwat
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of SK163095A3 publication Critical patent/SK163095A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/18—Ring systems of four or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B11/00—Diaryl- or thriarylmethane dyes
    • C09B11/28—Pyronines ; Xanthon, thioxanthon, selenoxanthan, telluroxanthon dyes
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B15/00—Acridine dyes
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B5/00—Dyes with an anthracene nucleus condensed with one or more heterocyclic rings with or without carbocyclic rings
    • C09B5/002—Dyes with an anthracene nucleus condensed with one or more heterocyclic rings with or without carbocyclic rings the heterocyclic rings being condensed in peri position and in 1-2 or 2-3 position
    • C09B5/004—Dyes with an anthracene nucleus condensed with one or more heterocyclic rings with or without carbocyclic rings the heterocyclic rings being condensed in peri position and in 1-2 or 2-3 position only O-containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B57/00—Other synthetic dyes of known constitution
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B57/00—Other synthetic dyes of known constitution
    • C09B57/08—Naphthalimide dyes; Phthalimide dyes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
SK1630-95A 1993-06-24 1994-06-15 Bis-imides and pharmaceutical compositions on their base SK163095A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/080,862 US5416089A (en) 1993-06-24 1993-06-24 Polycyclic and heterocyclic chromophores for bis-imide tumoricidals
PCT/US1994/006442 WO1995000490A1 (en) 1993-06-24 1994-06-15 Bis-imide polycyclic and heterocyclic chromophores useful as tumoricidals

Publications (1)

Publication Number Publication Date
SK163095A3 true SK163095A3 (en) 1996-09-04

Family

ID=22160120

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1630-95A SK163095A3 (en) 1993-06-24 1994-06-15 Bis-imides and pharmaceutical compositions on their base

Country Status (19)

Country Link
US (2) US5416089A (pt)
EP (1) EP0705250A1 (pt)
JP (1) JPH08511802A (pt)
KR (1) KR960703113A (pt)
CN (1) CN1125943A (pt)
AU (1) AU7171294A (pt)
BR (1) BR9407265A (pt)
CA (1) CA2165765A1 (pt)
CZ (1) CZ336795A3 (pt)
FI (1) FI956231A0 (pt)
HR (1) HRP940367A2 (pt)
HU (1) HUT75121A (pt)
IL (1) IL110033A0 (pt)
NO (1) NO955257L (pt)
PL (1) PL312272A1 (pt)
SK (1) SK163095A3 (pt)
TW (1) TW263506B (pt)
WO (1) WO1995000490A1 (pt)
ZA (1) ZA944370B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703089A (en) * 1994-04-28 1997-12-30 Knoll Aktiengesellschaft Dihydrodibenzisoquinolinediones
US5641782A (en) * 1995-02-16 1997-06-24 The Dupont Merck Pharmaceutical Company 3-aromatic and 3-heteroaromatic substituted bisnaphthalimides
FR2751655B1 (fr) * 1996-07-26 1998-08-28 Adir Nouveaux derives de bis-imides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE69909246D1 (de) * 1998-02-04 2003-08-07 Univ Texas Hemmung der menschlichen telomerase durch g-quadruplex interaktionverbindung
ES2191532B1 (es) * 2001-05-28 2005-02-16 Fundacion Universitaria San Pablo - Ceu Derivados de naftalimidas heterociclicas como agentes antiproliferativos.
EP1539150A4 (en) * 2002-07-08 2006-10-11 Chemgenex Pharmaceuticals Inc SYNTHESIS OF NAPHTHALIMIDES, INCLUDING AMONAFIDS, AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME
WO2005074599A2 (en) * 2004-01-30 2005-08-18 Chemgenex Pharmaceuticals, Inc. Naphthalimide dosing by n-acetyl transferase genotyping
AU2005249593A1 (en) * 2004-06-04 2005-12-15 Chemgenex Pharmaceuticals Inc. Methods of treating cellular proliferative disease using naphthalimide and PARP-1 inhibitors
US7947839B2 (en) * 2004-12-01 2011-05-24 Genentech, Inc. Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use
WO2006060533A2 (en) 2004-12-01 2006-06-08 Genentech, Inc. Conjugates of 1, 8-bis-naphthalimides with an antibody
RU2453536C2 (ru) * 2007-10-22 2012-06-20 Оркид Рисерч Лабораториз Лимитед Ингибиторы гистондезацетилазы
CN101638389B (zh) * 2008-03-03 2012-09-05 河南大学 一种含萘酰亚胺结构的多胺衍生物及其制备方法和应用
US9039695B2 (en) 2009-10-09 2015-05-26 Ethicon Endo-Surgery, Inc. Surgical generator for ultrasonic and electrosurgical devices
CN106167490B (zh) * 2016-08-10 2018-11-09 大连理工大学 一类含吲哚的咪唑并萘酰亚胺类衍生物及其合成和应用
CZ308568B6 (cs) 2018-12-03 2020-12-09 Univerzita Karlova Naftalimidofurany pro aplikace v molekulární biologii
JP6884920B2 (ja) * 2019-04-02 2021-06-09 旭化成株式会社 錠剤の保存安定性を向上させる方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3604827A1 (de) * 1986-02-15 1987-08-20 Bayer Ag Elektrophotographische toner
DE3707651A1 (de) * 1987-03-10 1988-09-22 Knoll Ag Bis-naphthalimide, ihre herstellung und verwendung
US5290931A (en) * 1990-02-21 1994-03-01 Hoechst Mitsubishi Kasei Co., Ltd. Water-insoluble naphthalic acid imide dyestuffs
US5086059A (en) * 1990-06-07 1992-02-04 Du Pont Merck Pharmaceutical Company Bis-naphthalimides as anticancer agents
US5206249A (en) * 1991-03-27 1993-04-27 Du Pont Merck Pharmaceutical Company Bis-naphthalimides containing amino-acid derived linkers as anticancer agents
US5206250A (en) * 1991-03-27 1993-04-27 Du Pont Merck Pharmaceutical Company Bis-naphthalimides containing amide and thioamide linkers as anticancer agents

Also Published As

Publication number Publication date
JPH08511802A (ja) 1996-12-10
CZ336795A3 (en) 1996-06-12
NO955257D0 (no) 1995-12-22
EP0705250A1 (en) 1996-04-10
ZA944370B (en) 1996-01-04
KR960703113A (ko) 1996-06-19
CN1125943A (zh) 1996-07-03
TW263506B (pt) 1995-11-21
NO955257L (no) 1996-02-26
HUT75121A (en) 1997-04-28
FI956231A7 (fi) 1995-12-22
HRP940367A2 (en) 1997-04-30
HU9503759D0 (en) 1996-02-28
IL110033A0 (en) 1994-10-07
FI956231L (fi) 1995-12-22
PL312272A1 (en) 1996-04-15
US5585382A (en) 1996-12-17
CA2165765A1 (en) 1995-01-05
US5416089A (en) 1995-05-16
AU7171294A (en) 1995-01-17
BR9407265A (pt) 1996-10-01
WO1995000490A1 (en) 1995-01-05
FI956231A0 (fi) 1995-12-22

Similar Documents

Publication Publication Date Title
SK163095A3 (en) Bis-imides and pharmaceutical compositions on their base
KR940000828B1 (ko) 항혈전성 강심제 이미다조 퀴놀린의 제조방법
SU1445556A3 (ru) Способ получени производных 2-оксоиндол-1-карбоксамида
US7238690B2 (en) Substituted heterocycle fused gamma-carbolines
CN103534254B (zh) 作为抗肿瘤剂的三环和四环吡唑并[3,4-b]吡啶化合物
CA2736097C (en) Carbazole compounds for inhibition of nf-kb activity
SK7032003A3 (en) Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists
EP0091241A2 (en) Condensed pyrrolinone derivatives, and their production
JPH09504519A (ja) ピリダジノキノリン化合物
SK280822B6 (sk) Imidazopyridíny, spôsob ich prípravy, farmaceutické prostriedky s ich obsahom a ich použitie
JP7611934B2 (ja) ピラゾロピリダジノン化合物、その医薬組成物及びその用途
DK164704B (da) 3,6-disubstituerede triazolo-oe3,4-aaa-ftalazinderivater, fremgangsmaade til fremstilling deraf, udgangsforbindelse til anvendelse i fremgangsmaaden samt anvendelse af og farmaceutisk praeparat indeholdende forbindelserne
DE60206952T2 (de) Imidazopyridinverbindungen als 5-ht4-rezeptormodulatoren
US6737424B2 (en) Alpha-substituted pyridazino quinoline compounds
CA2927830A1 (en) Quinazolinone and isoquinolinone derivative
EP1891067B1 (en) Androgen receptor modulator compounds and methods
HUP9904623A2 (hu) 1H-Pirido[3,4-b]indol-4-karboxamid-származékok,eljárás előállításukra és alkalmazásuk a gyógyászatban
CH682151A5 (pt)
CN101243087B (zh) 1,4-二氢吡啶-稠合杂环、其制备方法、应用以及含有其的组合物
CA2977752C (en) Benzimidazole compound for preventing or treating a disease caused by abnormal prs activity, method for preparing the same and pharmaceutical composition comprising the same
WO2004087701A1 (en) Cyclic benzimidazoles
KR20030069192A (ko) 세로토닌 수용체 효능제 및 길항제로서 치환된피라지노퀴녹살린 유도체
JPH0249784A (ja) 三環式縮合ピリミジン誘導体
WO2001014384A1 (en) Tricyclic dihydrobenzofuran derivatives, process for the preparation thereof and agents
NO774216L (no) Fremgangsmaate for fremstilling av benzimidazolderivater